Ofloxacine Sandoz (Ofloxacin)

Ofloxacin belongs to the fluoroquinolone class and works by inhibiting bacterial DNA gyrase and topoisomerase IV. These enzymes are essential for DNA replication and transcription. By blocking them, Ofloxacin prevents bacterial cells from reproducing, leading to cell death and resolution of the infection.

The dosage of Ofloxacine Sandoz is determined by the prescribing clinician based on the type and severity of infection, patient age, renal function, and other clinical factors. Healthcare professionals set the appropriate dose and treatment duration according to established guidelines.

Ofloxacin is generally contraindicated during pregnancy and lactation unless the potential benefit justifies the risk to the fetus or infant. It crosses the placenta and may be excreted in breast milk, so clinicians evaluate alternatives before prescribing to pregnant or nursing women.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Ofloxacine Sandoz offers a broad spectrum of activity similar to other fluoroquinolones, but its pharmacokinetic profile, dosing convenience, and specific bacterial susceptibility patterns may differ. Clinicians choose it based on local resistance data, patient tolerance, and the infection site, balancing efficacy with safety considerations.

Store Ofloxacine Sandoz tablets at room temperature, below 25 °C, in the original packaging to protect from moisture and light. Do not store in bathrooms or near heat sources, and keep out of reach of children.

Ofloxacine Sandoz is administered orally, typically as a tablet taken with a full glass of water. It may be taken with or without food, but patients should avoid concurrent intake of antacids containing magnesium or aluminium, which can impair absorption.

Serious risks include tendon rupture or tendinitis, especially in older adults or those on corticosteroids; QT interval prolongation leading to cardiac arrhythmias; severe allergic reactions such as anaphylaxis; and Clostridioides difficile‑associated diarrhoea. Patients should be advised to report any sudden joint pain, palpitations, or severe rash promptly.

Ofloxacine Sandoz should be avoided in patients with a known hypersensitivity to Ofloxacin or other fluoroquinolones, those with a history of tendon disorders related to fluoroquinolone use, pregnant or breastfeeding women unless absolutely necessary, and individuals taking medications that significantly prolong the QT interval without careful monitoring.